![](/img/cover-not-exists.png)
Effective oral hypomethylating drugs in intermediate-risk or high-risk myelodysplasia: a breakthrough?
de Witte, TheoVolume:
6
Language:
english
Journal:
The Lancet Haematology
DOI:
10.1016/S2352-3026(19)30025-0
Date:
April, 2019
File:
PDF, 104 KB
english, 2019